In response to increased pressure to reduce study timelines and costs, the pharmaceutical industry has been deploying eClinical solutions. Investigative sites are now inundated with technologies, adding to their already heavy workload burden. However, are better technologies just part of the solution? Numerous industry initiatives are also now available to help sites improve operational efficiencies.
Faced with this myriad of options, what are the challenges and opportunities currently facing the adoption and deployment of these technologies and initiatives? A panel of site-centric industry organizations will present and discuss the findings from a new study aimed at addressing these questions.
This webinar will focus on understanding the sites’ perspective on these issues, which is of paramount importance in guiding and sustaining global clinical research.
This webinar is applicable to:
- Investigative sites engaged or wishing to engage in clinical studies
- Sponsor and CRO roles responsible for site identification, feasibility assessment, selection and activation
- Sponsor and CRO roles responsible for project management of studies and operational excellence
Casey Orvin, President, Society for Clinical Research Sites (SCRS)
Casey Orvin has nearly 20 years of experience working with the site community and is a champion for clinical research sites with experience creating outreach programs, developing key partnerships and generating study opportunities for hundreds of clinical research sites globally. Casey previously served as Executive Vice President of Business Development for Synexus and Vice President of Marketing and Sponsor Recruitment for Clinical Research Advantage.Message Presenter
Jim Kremidas, Executive Director, Association of Clinical Research Professionals (ACRP)
Jim is currently the Executive Director for ACRP, a not-for-profit association that represents the clinical research enterprise. Prior to that, he conducted consulting services for a variety of clients including support for investigator sites, academic institutions, sponsors and suppliers. He was the Senior Vice President of Patient Recruitment at two different large CROs for over six years where he and his team were responsible for developing and implementing patient enrollment strategies for global clinical trials. Prior to that, he spent 24 years with Eli Lilly and Company.
Jim is on the advisory board of CISCRP (a non-profit organization focused on enhancing patient participation in clinical trials) and is also a volunteer for the Clinical Trial Transformation Initiative (CTTI) with Duke and the National Institutes of Health. Jim is a frequent presenter at Industry Conferences and his papers have been published in a wide variety of trade journals.Message Presenter
Joan Chambers, VP of Marketing & Strategy, Clin-X (ClinEdge, BTC Network, GuideStar Research)
Joan Chambers is the Vice President of Marketing and Strategy at Clin-X, a global service solutions provider for research sites, patients and healthcare organizations. Over her 20+ years of experience in the life sciences industry, she has worked in senior management roles at SCORR Marketing, CenterWatch, Cambridge Healthtech Institute, Tufts Center for the Study of Drug Development at Tufts University and PAREXEL International. Joan holds a Bachelor of Science in Marketing.
Joan is on the board of directors for Greater Gift, The Center for Information and Study on Clinical Research Participation (CISCRP), the US PharmaTimes Steering Committee for CROY, Steering Committee for Pharma Intelligence/Informa Clinical & Research Excellence Awards, Steering Committee for PopUp Star and is an active member of the Association of Clinical Research Professionals (ACRP) and the Drug Information Association (DIA).Message Presenter
Elvin Thalund, Director, Industry Strategy, Oracle Health Sciences
Elvin is a recognized industry expert in clinical trials, having over 20 years of experience working as a Clinical Business Analyst Consultant at major pharmaceutical companies including Hoffmann-La Roche and Johnson & Johnson. Elvin works as a product strategist and system architect in Oracle Health Sciences’s effort to optimize study startup. Elvin is the Co-Chair on the TMF Reference Model Exchange Mechanism and holds a Master of Science in Industrial Engineering from Aalborg Universitet.Message Presenter
Who Should Attend?
Senior level professionals involved in:
- Clinical Operations
- Regulatory Compliance
- Project Management
- Regulatory Affairs
- Operational Oversight
- Clinical Reporting
What You Will Learn
Attendees will explore:
- The impact of the ‘One and Done’ Syndrome on investigative sites
- Study engagement trends associated with site type and location and their subsequent impact on patient enrollment
- The impact of eClinical technology, both current and future, including consolidated investigator platforms, on the investigative site and their ability to conduct clinical trials
- The impact of numerous site-centric industry initiatives
- The impact of Decentralized Clinical Trials (DCTs) on investigative sites
- Technology trends and perceptions with regards to previous research
Oracle Health Sciences
Oracle Health Sciences breaks down barriers and opens new pathways to unify people and processes to bring new drugs to market faster. As a leader in Life Sciences technology, Oracle Health Sciences is trusted by 29 of the top 30 pharma, 10 of the top 10 biotech and 10 of the top 10 CROs for managing clinical trials and pharmacovigilance around the globe. Learn more at https://www.oracle.com/life-sciences/.